850366C

18:0 (9,10dibromo) PC

1,2-di-(9,10-dibromo)stearoyl-sn-glycero-3-phosphocholine, chloroform

• Synonym(e): 1,2-di-(9,10-dibromooctadecanoyl)-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₄₄H₈₄NO₈PBr₄
• CAS-Nummer: 217075-01-9
• Molekulargewicht: 1105.73
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (850366C-10mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 850366C
• Konzentration: 10 mg/mL (850366C-10mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

18:0 (9,10dibromo) PC (1,2-di-(9,10-dibromo)stearoyl-sn-glycero-3-phosphocholine) is a zwitterionic brominated phospholipid.

Anwendung

18:0 (9,10dibromo) PC (1,2-di-(9,10-dibromo)stearoyl-sn-glycero-3-phosphocholine) may be used:

• in the preparation of liposomes/small unilamellar vesicles (SUVs)
• in the preparation of large unilamellar vesicles (LUVs) to facilitate vesicles sedimentation
• as a component in liposomes

Biochem./physiol. Wirkung

Phosphatidylcholine (PC) forms a hydrophobic surface in the mucus by acting as a surfactant resulting in the inhibition of penetrance of bacteria.

Verpackung

5 mL Clear Glass Sealed Ampule (850366C-10mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3